{"created":"2014-10-27T19:24:35+00:00","modified":"2014-10-30T23:31:33+00:00","valid":{"from":"2014-10-30T23:31:32+00:00","to":"3014-10-30T23:31:32+00:00"},"hreflang":"en","title":"Company Seeks Approval For Experimental Ebola Drug","published":"2014-08-07T18:37:00+00:00","teaser":"The head of the Massachusetts company explains how the treatment would work and what it would take to get it to patients.","itags":["npr_api","338622855"],"guid":"1d22ca17-2976-413d-ae53-aacc5a103922","contentencoded":"<p>There is no known cure for the Ebola virus, but a number of labs have been working on one. The two American relief workers recently flown back from Liberia have been receiving an experimental treatment produced by a company in San Diego.</p><p>Another company, Cambridge, Mass.-based Sarepta Therapeutics, also has an experimental drug. The company&#8217;s CEO, <strong>Chris Garabedian</strong>, tells <a href=\"https://hereandnow.wbur.org/\"><em>Here & Now&#8217;</em></a>s Robin Young how this treatment would work, and what it takes to get the drug to patients.</p><h4>Guest</h4><ul><li><a href=\"http://www.sarepta.com/company/senior-leadership\" target=\"_blank\"><strong>Chris Garabedian</strong></a>, CEO of Sarepta Therapeutics.</li></ul>  <div class=\"fullattribution\">Copyright 2014 NPR. To see more, visit <a href=\"http://www.npr.org/\">http://www.npr.org/</a>.<img src=\"http://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Company+Seeks+Approval+For+Experimental+Ebola+Drug&utme=8(APIKey)9(MDAyOTcwNDAwMDEyODgyMDkwMTgwNzY3YQ001)\"/></div>","audio":[{"meta":{"duration":"455"},"type":"audio/m3u","href":"http://api.npr.org/m3u/1338622858-b27219.m3u?orgId=1&ft=3&f=338622855"}]}